News
Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...
Basel: Roche has received approval from the US Food and Drug Administration (FDA) for Susvimo (ranibizumab injection) 100 ...
One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...
Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...
The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...
HIF has been implicated in diabetic retinopathy and other eye diseases before. The protein can trigger a chain reaction, switching on overproduction of other proteins which lead to overgrowth and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results